Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV-3 study-Reference-Cited by-同舟云学术

Corticosteroid-free immunosuppression with daclizumab in HCV+ liver transplant recipients: 1-year interim results of the HCV-3 study

Published:2007 Issue:11 Volume:13 Page:1521-1531
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Klintmalm Goran B.G.,Washburn W. Kenneth,Rudich Steven M.,Heffron Thomas G.,Teperman Lewis W.,Fasola Carlos,Eckhoff Devin E.,Netto George J.,Katz Eliezer

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Reference49 articles.

1. The challenge of progressive hepatitis C following liver transplantation

2. Projecting future complications of chronic hepatitis C in the United States

3. Hepatitis C virus kinetics during and immediately after liver transplantation

4. Prognosis of chronic hepatitis c: Results of a large, prospective cohort study

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S2k-Leitlinie Lebertransplantation der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Allgemein- und Viszeralchirurgie (DGAV);Zeitschrift für Gastroenterologie;2024-09

2. Multidirectional facets of obesity management in the metabolic syndrome population after liver transplantation;Immunity, Inflammation and Disease;2021-10

3. Current management & future directions in post-liver transplant recurrence of viral hepatitis;Journal of Liver Transplantation;2021-07

4. Safety and Efficacy of Budesonide for Liver Transplant Immune Suppression: Results of a Pilot Phase 2a Trial;Liver Transplantation;2020-08-19

5. Immunosuppression in Donation After Circulatory Death Liver Transplantation: Can Induction Modify Graft Survival?;Liver Transplantation;2020-08-04